IRMD RSI Chart
Last 7 days
-2.3%
Last 30 days
-4.9%
Last 90 days
-6.7%
Trailing 12 Months
16.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 56.5M | 59.9M | 63.0M | 65.6M |
2022 | 44.9M | 47.8M | 50.3M | 53.3M |
2021 | 32.3M | 35.3M | 38.5M | 41.8M |
2020 | 38.8M | 36.3M | 34.1M | 31.7M |
2019 | 31.8M | 33.6M | 36.0M | 38.5M |
2018 | 25.0M | 26.9M | 28.8M | 30.4M |
2017 | 28.7M | 24.4M | 22.4M | 23.1M |
2016 | 33.6M | 35.8M | 35.3M | 32.5M |
2015 | 19.1M | 22.0M | 26.4M | 31.6M |
2014 | 12.4M | 13.5M | 14.6M | 15.7M |
2013 | 0 | 0 | 0 | 11.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 27, 2023 | susi roger e. | sold | -232,547 | 46.5094 | -5,000 | ceo, president, chairman |
Dec 26, 2023 | susi roger e. | sold | -230,000 | 46.00 | -5,000 | ceo, president, chairman |
Dec 21, 2023 | susi roger e. | gifted | - | - | -300,000 | ceo, president, chairman |
Dec 19, 2023 | susi roger e. | sold | -225,696 | 45.1393 | -5,000 | ceo, president, chairman |
Dec 18, 2023 | susi roger e. | sold | -220,402 | 44.0805 | -5,000 | ceo, president, chairman |
Dec 14, 2023 | hawkins james b | acquired | 42,085 | 9.84 | 4,277 | - |
Dec 14, 2023 | hawkins james b | sold | -190,687 | 44.5843 | -4,277 | - |
Dec 13, 2023 | hawkins james b | acquired | 51,355 | 9.84 | 5,219 | - |
Dec 13, 2023 | hawkins james b | sold | -223,540 | 42.8319 | -5,219 | - |
Dec 12, 2023 | susi roger e. | sold | -214,113 | 42.8226 | -5,000 | ceo, president, chairman |
Which funds bought or sold IRMD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC Financial Services Group, Inc. | sold off | -100 | -2,130 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 3.57 | 1,976,620 | 20,263,800 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 92.89 | 2,646,550 | 5,134,640 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.41 | 10,600 | 172,506 | -% |
Feb 23, 2024 | CIM, LLC | new | - | 395,621 | 395,621 | 0.06% |
Feb 15, 2024 | Farther Finance Advisors, LLC | unchanged | - | 74.00 | 1,139 | -% |
Feb 15, 2024 | Legal & General Group Plc | added | 2.82 | 39,155 | 430,364 | -% |
Feb 15, 2024 | State of Wyoming | reduced | -46.5 | -30,071 | 40,255 | 0.01% |
Feb 15, 2024 | BARCLAYS PLC | added | 83.16 | 454,000 | 926,000 | -% |
Feb 14, 2024 | Ballast Asset Management, LP | added | 44.39 | 606,398 | 1,719,550 | 1.09% |
Unveiling iRadimed Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to iRadimed Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 196.9B | 40.1B | 34.4 | 4.91 | ||||
BDX | 71.2B | 19.5B | 56.69 | 3.65 | ||||
ALGN | 24.6B | 3.9B | 55.33 | 6.38 | ||||
BAX | 21.7B | 14.8B | 8.16 | 1.46 | ||||
MID-CAP | ||||||||
BIO | 10.2B | 2.7B | -16.04 | 3.83 | ||||
HSIC | 9.7B | 12.3B | 23.21 | 0.78 | ||||
ATR | 9.5B | 3.5B | 33.57 | 2.74 | ||||
XRAY | 6.9B | 4.0B | -51.36 | 1.74 | ||||
AXNX | 3.5B | 366.4M | -577.22 | 9.59 | ||||
PDCO | 2.5B | 6.6B | 12.86 | 0.38 | ||||
SMALL-CAP | ||||||||
AHCO | 1.5B | 3.2B | -2.23 | 0.47 | ||||
ANIK | 379.3M | 166.7M | -4.59 | 2.28 | ||||
ANGO | 227.2M | 329.5M | -16.09 | 0.69 | ||||
APYX | 43.3M | 52.3M | -2.31 | 0.83 | ||||
AEMD | 4.5M | 3.7M | -0.37 | 1.19 |
iRadimed Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 5.7% | 17,452 | 16,505 | 16,130 | 15,475 | 14,864 | 13,407 | 12,722 | 12,311 | 11,873 | 10,907 | 9,810 | 9,224 | 8,546 | 7,699 | 6,795 | 8,678 | 10,891 | 9,963 | 9,226 | 8,438 | 8,339 |
Cost Of Revenue | 10.1% | 4,039 | 3,667 | 3,944 | 3,754 | 3,643 | 2,865 | 2,582 | 2,931 | 2,623 | 2,502 | 2,478 | 2,162 | 2,107 | 1,958 | 1,865 | 2,214 | 2,742 | 2,168 | 1,858 | 2,048 | 1,982 |
Gross Profit | 4.5% | 13,413 | 12,837 | 12,186 | 11,721 | 11,220 | 10,543 | 10,140 | 9,380 | 9,250 | 8,406 | 7,332 | 7,062 | 6,439 | 5,741 | 4,930 | 6,464 | 8,149 | 7,795 | 7,367 | 6,390 | 6,357 |
Operating Expenses | 19.1% | 8,253 | 6,932 | 7,223 | 7,714 | 6,967 | 6,410 | 5,973 | 6,305 | 6,140 | 5,319 | 5,488 | 5,285 | 5,788 | 4,956 | 7,859 | 5,727 | 5,910 | 5,276 | 4,992 | 4,876 | 4,564 |
S&GA Expenses | 16.2% | 3,329 | 2,864 | 2,948 | 3,000 | 3,665 | 3,037 | 2,908 | 3,070 | 3,121 | 2,586 | 2,470 | 2,379 | 3,069 | 2,282 | 2,374 | 2,434 | 2,562 | 2,297 | 2,200 | 2,111 | 2,049 |
R&D Expenses | 43.7% | 650 | 453 | 962 | 794 | 605 | 492 | 663 | 519 | 495 | 481 | 454 | 476 | 513 | 477 | 483 | 430 | 379 | 370 | 331 | 353 | 368 |
EBITDA Margin | 4.8% | 0.34* | 0.33* | 0.31* | 0.32* | 0.32* | 0.32* | 0.32* | 0.28* | 0.27* | 0.23* | 0.18* | 0.05* | - | - | - | - | - | - | - | - | - |
Income Taxes | -14.9% | 1,142 | 1,341 | 1,119 | 944 | 1,030 | 810 | 939 | 573 | -779 | 518 | 388 | 384 | 27.00 | -280 | -798 | -933 | -887 | 174 | 365 | -239 | 169 |
Earnings Before Taxes | -11.3% | 5,682 | 6,409 | 5,298 | 4,350 | 4,704 | 4,237 | 4,180 | 3,060 | 3,113 | 3,094 | 1,857 | 1,771 | 665 | 794 | -2,911 | 836 | 2,354 | 2,629 | 2,454 | 1,606 | 1,876 |
EBT Margin | 0.6% | 0.33* | 0.33* | 0.31* | 0.31* | 0.30* | 0.29* | 0.28* | 0.25* | 0.24* | 0.19* | 0.14* | 0.01* | - | - | - | - | - | - | - | - | - |
Net Income | -10.4% | 4,540 | 5,067 | 4,180 | 3,406 | 3,674 | 3,427 | 3,241 | 2,487 | 3,893 | 2,576 | 1,470 | 1,387 | 637 | 1,075 | -2,112 | 1,769 | 3,242 | 2,455 | 2,089 | 1,846 | 1,707 |
Net Income Margin | 1.1% | 0.26* | 0.26* | 0.25* | 0.24* | 0.24* | 0.26* | 0.26* | 0.23* | 0.22* | 0.16* | 0.13* | 0.03* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 211.7% | 3,381 | 1,085 | 3,309 | -1,749 | 2,781 | 3,746 | 1,451 | 1,243 | 3,275 | 3,228 | 3,462 | 811 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 5.4% | 92.00 | 87.00 | 81.00 | 76.00 | 86.00 | 80.00 | 76.00 | 72.00 | 83.00 | 78.00 | 76.00 | 72.00 | 71.00 | 70.00 | 69.00 | 68.00 | 67.00 | 63.00 | 57.00 | 54.00 | 48.00 |
Current Assets | 5.7% | 76.00 | 72.00 | 66.00 | 61.00 | 77.00 | 72.00 | 68.00 | 66.00 | 76.00 | 72.00 | 69.00 | 65.00 | 64.00 | 63.00 | 60.00 | 61.00 | 59.00 | 56.00 | 50.00 | 47.00 | 45.00 |
Cash Equivalents | 6.5% | 50.00 | 47.00 | 46.00 | 43.00 | 58.00 | 56.00 | 52.00 | 50.00 | 62.00 | 58.00 | 55.00 | 51.00 | 50.00 | 48.00 | 45.00 | 45.00 | 43.00 | 39.00 | 32.00 | 30.00 | 28.00 |
Inventory | 9.9% | 13.00 | 12.00 | 8.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 4.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 |
Net PPE | 4.5% | 9.00 | 9.00 | 9.00 | 9.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | 61.5% | 21.00 | 13.00 | 12.00 | 11.00 | 12.00 | 10.00 | 10.00 | 10.00 | 11.00 | 11.00 | 11.00 | 9.00 | 10.00 | 10.00 | 10.00 | 10.00 | 11.00 | 11.00 | 10.00 | 10.00 | 6.00 |
Current Liabilities | 107.1% | 16.00 | 8.00 | 8.00 | 7.00 | 9.00 | 6.00 | 6.00 | 6.00 | 7.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 |
Shareholder's Equity | -4.2% | 71.00 | 75.00 | 69.00 | 64.00 | 74.00 | 70.00 | 66.00 | 63.00 | 72.00 | 68.00 | 65.00 | 63.00 | 61.00 | 61.00 | 58.00 | 58.00 | 56.00 | 52.00 | 47.00 | 45.00 | 42.00 |
Retained Earnings | -7.4% | 43.00 | 47.00 | 42.00 | 37.00 | 47.00 | 44.00 | 40.00 | 37.00 | 47.00 | 43.00 | 41.00 | 39.00 | 38.00 | 37.00 | 36.00 | 38.00 | 36.00 | 33.00 | 31.00 | 29.00 | 27.00 |
Additional Paid-In Capital | 1.0% | 28.00 | 28.00 | 27.00 | 27.00 | 26.00 | 26.00 | 26.00 | 26.00 | 25.00 | 25.00 | 24.00 | 24.00 | 24.00 | 24.00 | 22.00 | 20.00 | 19.00 | 19.00 | 17.00 | 16.00 | 15.00 |
Shares Outstanding | 0.5% | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 12.00 | 12.00 | 12.00 | 12.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 242 | - | - | - | 185 | - | - | - | 146 | - | - | - | 107 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 180.9% | 3,912 | 1,393 | 3,514 | 4,646 | 3,039 | 3,938 | 1,639 | 1,426 | 3,366 | 3,378 | 3,571 | 943 | 2,496 | 1,334 | 791 | 1,197 | 3,949 | 3,138 | 2,480 | 665 | 3,542 |
Share Based Compensation | 3.2% | 551 | 534 | 568 | 534 | 427 | 393 | 121 | 453 | 392 | 777 | -57.56 | 348 | 318 | 417 | 2,659 | 569 | 549 | 456 | 468 | 382 | 402 |
Cashflow From Investing | -44.1% | -632 | -439 | -378 | -6,557 | -471 | -556 | 78.00 | -424 | 260 | -220 | 783 | -173 | 301 | -110 | 287 | -230 | 935 | 1,369 | 339 | 557 | 1,074 |
Cashflow From Financing | -737.1% | -262 | -31.37 | -89.77 | -13,272 | -198 | 52.00 | -5.72 | -12,554 | 2.00 | 54.00 | 4.00 | -36.25 | -277 | 868 | -256 | 188 | -39.95 | 1,708 | -82.20 | 434 | -288 |
Dividend Payments | - | - | - | - | 13,223 | - | - | - | 12,559 | - | - | - | - | - | - | - | - | - | - | - | - | - |
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
STATEMENTS OF OPERATIONS | ||
Revenue | $ 65,562,296 | $ 53,303,145 |
Cost of revenue | 15,404,027 | 12,020,742 |
Gross profit | 50,158,269 | 41,282,403 |
Operating expenses: | ||
General and administrative | 15,122,065 | 10,697,067 |
Sales and marketing | 12,142,090 | 12,679,610 |
Research and development | 2,858,656 | 2,278,081 |
Total operating expenses | 30,122,811 | 25,654,758 |
Income from operations | 20,035,458 | 15,627,645 |
Other income, net | 1,702,798 | 553,104 |
Income before provision for income taxes | 21,738,256 | 16,180,749 |
Provision for income tax expense | 4,545,480 | 3,352,262 |
Net income | $ 17,192,776 | $ 12,828,487 |
Net income per share: | ||
Basic (in dollars per share) | $ 1.36 | $ 1.02 |
Diluted (in dollars per share) | $ 1.35 | $ 1.02 |
Weighted average shares outstanding: | ||
Basic (in shares) | 12,602,948 | 12,562,856 |
Diluted (in shares) | 12,722,530 | 12,635,971 |
BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 49,762,198 | $ 57,960,864 |
Accounts receivable, net of allowance for doubtful accounts of $368,835 as of December 31, 2023, and $160,498 as of December 31, 2022 | 12,224,273 | 13,274,521 |
Inventory, net | 12,821,194 | 5,369,233 |
Prepaid expenses and other current assets | 1,193,447 | 630,960 |
Prepaid income taxes | 254,093 | |
Total current assets | 76,001,112 | 77,489,671 |
Property and equipment, net | 9,288,625 | 2,399,812 |
Intangible assets, net | 2,519,053 | 2,069,439 |
Operating lease right-of-use asset | 2,043,043 | 2,205,286 |
Deferred tax asset, net | 2,122,816 | 700,867 |
Other assets | 181,449 | 648,672 |
Total assets | 92,156,098 | 85,513,747 |
Current liabilities: | ||
Accounts payable | 1,857,091 | 1,799,316 |
Accrued payroll and benefits | 2,775,103 | 2,871,890 |
Other accrued taxes | 103,241 | 121,919 |
Warranty reserve | 117,463 | 94,030 |
Deferred revenue | 2,570,407 | 3,373,122 |
Dividend payable | 7,975,997 | |
Current portion of operating lease liabilities | 427,963 | 293,466 |
Other current liabilities | 250,000 | |
Accrued income taxes | 250,041 | |
Total current liabilities | 16,327,306 | 8,553,743 |
Deferred revenue | 2,793,548 | 1,375,197 |
Operating lease liabilities, less current portion | 1,615,080 | 1,911,820 |
Total liabilities | 20,735,934 | 11,840,760 |
Stockholders' equity: | ||
Common stock; $0.0001 par value; 31,500,000 shares authorized; 12,660,313 shares issued and outstanding as of December 31, 2023, and 12,591,004 shares issued and outstanding as of December 31, 2022 | 1,265 | 1,259 |
Additional paid-in capital | 28,160,745 | 26,407,446 |
Retained earnings | 43,258,154 | 47,264,282 |
Total Stockholders' Equity | 71,420,164 | 73,672,987 |
Total liabilities and stockholders' equity | $ 92,156,098 | $ 85,513,747 |
 | Mr. Roger E. Susi |
---|---|
 | www.iradimed.com |
 | 123 |